ecteinascidin 743 has been researched along with Leukocytopenia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alfaro, V; Blay, JY; Chawla, SP; Hendifar, A; Hohenberger, P; Lardelli, P; Leahy, MG; Nguyen, BB; Nieto, A; Patel, SR; Penel, N; Piperno-Neumann, S; Santoro, A; Staddon, AP | 1 |
Alfaro, V; Chu, Q; Forouzesh, B; Gómez, J; Hidalgo, M; Jimeno, J; Lebedinsky, C; Mita, A; Mita, M; Rowinsky, EK; Schwartz, G; Zintl, P | 1 |
Alfaro, V; Chu, Q; Forouzesh, B; Lebedinsky, C; Mita, A; Nieto, A; Rowinsky, EK; Schwartz, G; Soto-Matos, A; Tolcher, AW | 1 |
Bidzinski, M; Ghatage, P; Gorbounova, VA; Herzog, TJ; Kaye, SB; Krasner, CN; Lebedinsky, CA; Lisyanskaya, AS; Makhson, AN; Monk, BJ; Muggia, FM; Nam, JH; Ngan, HY; Park, YC; Poveda, AM; Pujade-Lauraine, E; Rolski, J; Shen, K; Vergote, IB; Vermorken, JB | 1 |
4 trial(s) available for ecteinascidin 743 and Leukocytopenia
Article | Year |
---|---|
Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Doxorubicin; Drug Administration Schedule; Fatigue; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Nausea; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Translocation, Genetic; Treatment Outcome; Young Adult | 2014 |
Phase I and pharmacokinetic study of trabectedin as a 1- or 3-hour infusion weekly in patients with advanced solid malignancies.
Topics: Adult; Aged; Anemia; Antineoplastic Agents, Alkylating; Area Under Curve; Creatine Kinase; Dioxoles; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Tetrahydroisoquinolines; Trabectedin; Transaminases; Young Adult | 2009 |
Phase I and pharmacokinetic study of sequential paclitaxel and trabectedin every 2 weeks in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Dioxoles; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Feasibility Studies; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Paclitaxel; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Young Adult | 2010 |
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Doxorubicin; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Leukopenia; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neutropenia; Ovarian Neoplasms; Polyethylene Glycols; Stomatitis; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome | 2010 |